Sim M K, Choo M H, Qiu X S
Department of Pharmacology Faculty of Medicine, National University of Singapore.
Biochem Pharmacol. 1994 Aug 30;48(5):1043-6. doi: 10.1016/0006-2952(94)90376-x.
The particulate enzyme that degrades angiotensin I (ANG I) to [des-aspartate1]angiotensin I ([des-Asp1]ANG I) in the hypothalamic homogenate of the rat has been established as a specific aminopeptidase. The major characteristics is its resistance to inhibition by 10(-4) M amastatin, bestatin and EDTA. Among the four amino acyl-beta-naphthylamides (aspartyl, glutamyl-, arginyl- and leucyl-beta-naphthylamide), aspartyl-beta-naphthylamide is the most susceptible substrate of the enzyme; being degraded at twice the rate of arginyl-, and leucyl-beta-naphthylamide, and six times that of glutamyl-beta-naphthylamide. Although the precise role of this aminopeptidase has yet to be determined, its presence establishes the existence of a specific pathway for the degradation of ANG I that bypasses the formation of ANG II. The relationship between degradation and hypertension is shown by our recent findings that the formation of [des-Asp1]ANG I form ANG I in the hypothalamic homogenate of the spontaneously hypertensive rat (SHR) is significantly enhanced, and the findings of other investigators that the production of ANG II by neuronal cultures of the SHR is significantly decreased.
在大鼠下丘脑匀浆中,能将血管紧张素I(ANG I)降解为[去天冬氨酸1]血管紧张素I([des-Asp1]ANG I)的颗粒酶已被确认为一种特异性氨肽酶。其主要特性是对10⁻⁴ M的抑氨肽酶素、苯丁抑制素和乙二胺四乙酸(EDTA)具有抗性。在四种氨酰基-β-萘酰胺(天冬氨酰基、谷氨酰基、精氨酰基和亮氨酰基-β-萘酰胺)中,天冬氨酰基-β-萘酰胺是该酶最易作用的底物;其降解速度是精氨酰基和亮氨酰基-β-萘酰胺的两倍,是谷氨酰基-β-萘酰胺的六倍。尽管这种氨肽酶的确切作用尚未确定,但其存在表明存在一条绕过血管紧张素II形成的ANG I特异性降解途径。我们最近的研究结果显示了降解与高血压之间的关系,即自发性高血压大鼠(SHR)下丘脑匀浆中由ANG I形成[des-Asp1]ANG I的过程显著增强,以及其他研究者的发现,即SHR神经元培养物中血管紧张素II的产生显著减少。